Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II–III trial

Maria Grazia Ghi, Adriano Paccagnella, Daris Ferrari, +34

Annals of Oncology

Randomized Phase III Trial of Neoadjuvant Chemotherapy in Head and Neck Cancer: 10-Year Follow-Up

P. L. Zorat, A. Paccagnella, G Cavaniglia, +15

JNCI Journal of the National Cancer Institute

Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study

Adriano Paccagnella, Maria Grazia Ghi, L. Loreggian, +12

Annals of Oncology

Advanced HeadNeuro-oncologyPhase IiRadiation TherapyHealth Sciences +8

Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial

Jean‐Pascal Machiels, Yungan Tao, Lisa Licitra, +185

The Lancet Oncology

Concurrent ChemoradiotherapyNeoadjuvant TherapySquamous Cell CarcinomaMedicineHead And Neck Cancer +4

Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis

Claire Petit, Benjamin Lacas, Jean‐Pierre Pignon, +165

The Lancet Oncology

Adaptive RadiotherapyAdvanced HeadNeck CancerMedicineHead And Neck Cancer +4

Concomitant chemoradiation (CRT) or cetuximab/RT (CET/RT) versus induction Docetaxel/ Cisplatin/5-Fluorouracil (TPF) followed by CRT or CET/RT in patients with Locally Advanced Squamous Cell Carcinoma of Head and Neck (LASCCHN). A randomized phase III factorial study (NCT01086826).

Maria Grazia Ghi, Adriano Paccagnella, Daris Ferrari, +17

Journal of Clinical Oncology

Surgical OncologyInduction TpfPharmacotherapyOral CancerRadiation Medicine +14

Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial

Adriano Paccagnella, Adolfo Favaretto, Francesco Oniga, +17

Lung Cancer

MedicinePhase Iii TrialPathologyCisplatin Versus CarboplatinAnti-cancer Agent +4

Adding Gemcitabine to Paclitaxel/Carboplatin Combination Increases Survival in Advanced Non–Small-Cell Lung Cancer: Results of a Phase II-III Study

Adriano Paccagnella, Francesco Oniga, Alessandra Bearz, +14

Journal of Clinical Oncology

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 100 randomized trials and 19,248 patients, on behalf of MACH-NC group

Pierre Blanchard, C. Landais, Claire Petit, +17

Annals of Oncology

Neck CancerMedicineClinical TrialsRandomized TrialsHead And Neck Cancer +7

Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study

Maria Grazia Ghi, Adriano Paccagnella, Paola D'Amanzo, +14

International Journal of Radiation Oncology*Biology*Physics

Concurrent ChemoradiotherapyRadiation TherapyNeoadjuvant TherapyMedicineNeoadjuvant Docetaxel +8